Biotechnology company, Biogen, has announced the appointment of Michael McDonell as CFO and vice president, effective 15 August.
McDonnell succeeds Jeffrey Capello, who has served as Biogen’s executive vice president and CFO since December 2017.
Capello will step down from his current role as CFO effective with McDonnell’s appointment on August 15, 2020 and will remain with the company until September 15, 2020, to assist with the transition
McDonell joins Biogen from clinical research company IQVIA, where he held the position of executive vice president and CFO.
At Biogen, McDonnell will lead the global finance function and operations, the company’s shared services center, information technology and investor relations groups.
CEO Michel Vounatsos: “I am thrilled to welcome Mike to Biogen at this exciting time when we have so many potential breakthrough therapies in our pipeline.
“Mike’s background and track record of accomplishments, including his extensive expertise in value-creating, strategic financial considerations, make him particularly well suited for Biogen at this moment in our history,”
McDonnell said: “As a business partner, I have long admired the strength of Biogen’s pipeline and its commitment to combating neurological diseases.
“I am excited by the multiple potential growth opportunities and the prospect of building on Biogen’s established position as a leader in neuroscience. I look forward to joining Biogen and working with my future colleagues to drive sustained performance and growth.”
